IntraNasal HEpaRin Trial (INHERIT) Statistical Analysis Plan

Statistical analysis plan for IntraNasal HEpaRin Trial (INHERIT) A randomised, placebo-controlled trial to Investigate the efficacy of intranasal heparin treatment to reduce transmission of SARS-CoV-2 infection and COVID disease among household contacts of SARS-CoV-2+ adults and children